Početna › Miastenija gravis › Ohio
Kliničke studije za Miastenija gravis u državi Ohio
13 studija za Miastenija gravis traži sudionike na lokacijama u državi Ohio.
Gradovi u državi Ohio
Službeni tekst studije (engleski)
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
- Mg0038 10103, Columbus
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07463521ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- University of Cincinnati Medical Center - Goodman St, Cincinnati
- Ohio State Martha Morehouse Outpatient Care, Columbus
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT07294170A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
- Mg0039 10103, Columbus
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT07465289ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- University of Cincinnati Medical Center - Goodman St, Cincinnati
- Ohio State Martha Morehouse Outpatient Care, Columbus
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT07284420Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- Miami Valley Hospital South, Centerville
- University of Cincinnati, Cincinnati
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT06463587A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Cleveland
- TG Therapeutics Investigational Trial Site, Columbus
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT06680037Zilucoplan for Severe gMG Exacerbations
- The Ohio State University, Columbus
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. kol 2026. · NCT07215949Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
- The Ohio State University, Columbus
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 21. kol 2026. · NCT06414954Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1038, Cincinnati
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 30. srp 2026. · NCT07039916A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Cleveland Clinic, Cleveland
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 27. srp 2026. · NCT04951622A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- University of Cincinnati Health Physicians - Clifton, Cincinnati
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 18. lip 2026. · NCT06456580A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- Ohio State University, Columbus
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 25. velj 2026. · NCT06626919Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Dayton
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 18. velj 2026. · NCT04202341Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.